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ABSTRACT
Nasopharyngeal carcinoma (NPC) is the most common malignancy found in the head and 
neck. It is a unique head and neck cancer due to its radiosensitivity. Therefore, radiotherapy 
becomes the main modality of therapy. Post-treatment evaluation of NPC is important to 
assess prognosis. Biopsy that is the gold standard for the evaluation can be performed 
with a narrow-band imaging (NBI) nasoendoscopy guide. This study aimed to determine 
the validity of NBI nasoendoscopic examination of NPC post-treatment biopsy. This study 
was a cross-sectional design for all post-treatment NPC patients who would undergo 
response assessment at the Department of Otorhinolaryngology, Head and Neck Surgery, 
Dr. Sardjito General Hospital, Yogyakarta. A total 40 patients during May-June 2018 period 
who underwent examination sequentially. Biopsy examination was carried out with NBI 
nasoendoscopy guidance and the results of biopsy were performed histopathological 
examination. Forty patients showed the results of NBI nasoendoscopic validity on NPC 
biopsy after treatment included sensitivity (85.7%), specificity (87.8%), positive predictive 
value (60%), negative predictive value (96.6 %), positive trend ratio (7.07), negative trend 
ratio (0.16), and accuracy (87.5%). Postoperative NBI nasoendoscopy features appear 
homogeneous (75%) and inhomogenous (25%). In conclusion, NBI nasoendoscopic 
validity on postoperative NPC biopsy is good.
ABSTRAK
Karsinoma nasofaring (KNF) merupakan keganasan paling sering di bagian kepala dan 
leher. Keganasan ini merupakan keganasan yang unik pada bagian kepala dan leher karena 
radiosensitivitasnya. Oleh Karena itu radioterapi menjadi modalitas terapi yang utama. 
Evaluasi pasca pengobatan pada KNF penting dilakukan untuk menentukan prognosisnya. 
Biopi yang merupakan standar emas evaluasi dapat dilakukan dengan  petunjuk 
nasoendoskopi narrow-band imaging (NBI). Penelitian ini bertujuan untuk menentukan 
validitas pemeriksaan nasoendoskopi NBI dari biopsi pasien KNF pasca pengobatan. 
Penelitian ini menggunakan rancangan potong lintang untuk semua pasien KNF pasca 
pengobatan yang akan menjalani penilaian respon di Departemen Otorinolaringologi, 
Bedah Kepala dan Leher, RSUP Dr. Sardjito, Yogyakarta.  Total 40 pasien selama Mei – 
Juni 2018 yang menjalani pemeriksaan secara berurutan. Pemeriksaan biopsy dilakukan 
sesusi petunjuk nasoendoskopi NBI dan hasil biopsi selanjutnya dilakukan pemeriksaan 
histopatologi. Empat puluh pasien menunjukkan validitas endoskopi NBI pada biopsy KNF 
setelah pengobatan yang meliputi sensitivitas (85,7%), spesifisitas (87,8%), nilai predeksi 
positif (60%), nilai predeksi negative (96,6%), rasio kecenderungan positif (7,07), rasio 
kecenderungan negative (0,16), akurasi (87,5%). Gambaran nasoendoskopi NBI setelah 
operasi kelihatan homogeny (75%) dan tidak homogeny (25%). Dapat disimpulkan, 
validitas nasoendoskopi NBI pada biopsi KNF setelah operasi bagus.  
Keywords: validity – nasoendoscopy - narrow-band imaging - post-treatment 
nasopharyngeal carcinoma 
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INTRODUCTION
Nasopharyngeal carcinoma (NPC) is 
one of the most common malignancies in 
ear, nose, throat-head, neck surgery (ENT-
HNS). It is a squamous cell carcinoma 
and originates from the nasopharyngeal 
epithelium in the Rosenmulleri fossa, which 
is a transitional area.1,2 Nasopharyngeal 
carcinoma contributes 0.7% of all cancers 
and ranks at 23rd from all malignancies 
worldwide.1,3 It is a unique head and neck 
cancer because of its radiosensitivity and it 
becomes the main modality of therapy that 
can be combined with chemotherapy in 
advanced cases.4-7 
The presence of irregular changes in 
blood vessel structure in the growth of 
neoplasms, especially in the nasopharynx, 
is very useful as a marker to identify the 
presence of malignancy both early stage 
and post-treatment residual. Tumors 
angiogenesis will increase tumor growth, 
so new blood vessels are usually irregular, 
brittle and tortuous.8,9
Narrow-band imaging (NBI) is 
an optical technique that can improve 
diagnostic sensitivity of a nasoendoscopic 
examination to assess tissue characteristics 
by using narrow bandwidth filters with 
absorption peaks in hemoglobin.10 The NBI 
uses 2 light spectrums, which is blue (415 
nm) that displays blood vessels in superficial 
mucosa and appear as a brownish color. 
Green light rays (540 nm) will show deeper 
blood vessels in the sub mucosa and appear 
as bluish color. Therefore, NBI can display 
vascular patterns or intraepithelial papillary 
capillary loops (IPCL).11-13The importance of post-treatment NPC 
evaluation to find out the results of complete 
or partial therapy. As well as changes in the 
condition of the nasopharyngeal mucosa 
due to exposure to chemoradiation, good 
visualization is needed when biopsy is 
performed at the right location as a diagnostic 
standard. This study aimed to determine the 
validity of NBI nasoendoscopic examination 
of nasopharyngeal carcinoma post-treatment 
biopsy.
MATERIALS AND METHODS
Subjects
This study was a screening test with a 
cross sectional study design. All research 
variable observations were done once in 
the same episode. Subjects were all NPC 
patients after chemoradiotherapy who would 
be evaluated for therapeutic response in 
Department of Otorhinolaryngology, Head 
and Neck Surgery, Faculty of Medicine, 
Public Health and Nursing, Universitas 
Gadjah Mada/Dr. Sardjito General Hospital, 
Yogyakarta during May to June 2018. 
Protocol of study
The inclusion criteria of this study 
were NPC patients 12 weeks after 
chemoradiotherapy, aged over 17 years old, 
willing to do nasopharyngeal biopsy, and 
willing to fill out and sign informed consent. 
The exclusion criteria were patients with 
nasopharyngeal secretions that filled the 
biopsy area, a mass that filled the choana 
and nasal cavity. The protocol of study has 
received approval from the Medicine and 
Health Research Ethics Committee, Faculty 
of Medicine, Public Health and Nursing, 
Universitas Gadjah Mada, Yogyakarta.
Statistical analysis
Data were presented as mean ± standard 
deviation (SD) or frequency or percentage. 
Sensitivity, specificity, positive predictive 
value, negative predictive value, accuracy, 
positive likelihood ratio, and negative 
likelihood ratio of NPC biopsy results 
using nasoendoscopy NBI were estimated. 
Moreover, receiver operating characteristic 
(ROC) curve was constructed and  areas 
under the curve (AUC) were calculated to 
assess the diagnostic accuracy of the NBI.
RESULTS 
The subjects who met the inclusion 
and exclusion criteria were 40 samples 
taken from 20 post-treatment NPC 
patients who would be conducted response 
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assessment, which was 12 weeks after the 
last chemoradiotherapy. The characteristics 
of subjects are presented in TABLE 1. The 
average age of NPC patients was 52.7 ± 9.7 
years with a minimum age of 35 years old 
of a NPC mass residual which also showed 
positive value from biopsy. The value of 
NBI examination specificity for estimating 
the absence of NPC mass residual after 
treatment was 87.8%, this showed the ability 
of the NBI to exclude the possibility of false 
negatives that are quite good.
The positive predictive value in this 
study was 60% which showed the probability 
of patients with positive NBI images giving 
positive biopsy results. This value was not 
very good due to the bias of thickening 
of the nasopharyngeal mucosa due to the 
effects of radiation or a residual mass of 
cancer. The negative predictive value in this 
study was good, about 96.6% so that the NBI 
examination can be relied upon to detect 
the possibility of clean therapeutic results 
(TABLE 2).
and a maximum of 65 years old. The higher 
age range was more than 50 years old (12 
cases/60%), while the age range of 30-40 
years old and 41-50 years old showed the 
same number of cases, each of 4 cases (20%). 
TABLE 1. Characteristics of subjects (n = 20)
Variable Value 
Age (mean ± SD years) 52.7 ± 9.7
•	 Minimum  (years) 35
•	 Maximum (years) 65
Age range [n (%) years]
•	 30–40 4 (20)
•	 41–50 4 (20)
•	 >50 12 (60)
Gender [n (%)]
•	 Male 14 (70)
•	 Female 6 (30)
Stadium [n (%)]
•	 Early (I & II) 2 (10)
•	 Advanced (III & IV) 18 (90)
Conventional Nasendoscopy [n 
(%)]
•	 No mass 34 (85)
•	 Suspect mass 6 (15)
Among 40 NPC samples after 
chemoradiotherapy there were 7 (17.5%) 
samples with positive biopsy results which 
showed that there were still NPC mass 
residuals (TABLE 2). Six of the 7 samples 
showed the results of NBI examination with 
suspected residual, and 1 of 7 gave a false 
negative NBI picture. The number of samples 
that showed negative biopsy results which 
means a complete therapeutic response and 
nasopharyngeal area were cancer-free in a 
number of 33 (82.5%) samples, including 
giving a negative NBI picture of 29 (72.5%) 
samples and 4 of 33 samples showing NBI 
false positives.
The assessment of the sensitivity of NBI 
examination in post-treatment NPC was 
85.7%, this indicates the ability of NBI to 
be good enough in detecting the possibility 
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TABLE 2. Sensitivity, specificity, positive predictive value, negative predictive 
value, positive likelihood ratio, and negative likelihood ratio of NPC 
biopsy results using nasoendoscopy NBI
Nasopharyngeal 
biopsy Total
+ -
Nasoendoscopy 
NBI
+ 6 (15 %)
(a)
4 (10%)
(b)
10 (25 %)
(a + b)
- 1 (2.5 %)
(c)
29 (72.5 %)
(d)
30 (75 %)
(c + d)
Total 7 (17.5 %)
(a + c)
33 (82.5 %)
(b + d)
40 (100 %)
(a + b + c + d)
Sensitivity = a/(a+c) = 85.7 %; Spesifisity = d/(d+b) = 87.8 %; Positive predictive value 
= a/(a+b) = 60 %; Negative predictive value = d/(c+d) = 96,6 %; Accuracy = a + d/(a 
+ b + c + d) = 87.5 %; positive likelihood ratio (LR+)=sensitivity/(1-spesifity): 7.07; 
negative likelihood ratio (LR-) = (1-sensitivity)/spesifity: 0.16
FIGURE 1. Receiver operating characteristic (ROC) curve
The result of LR+ of 7.07 indicate 
a positive NBI probability in the sample 
that was suspected to have residual with a 
positive NBI probability in a clean sample. 
The result of LR- was 0.16 which showed 
a negative probability ratio of NBI results 
in a sample that still had a residual with a 
probability of negative NBI results on a 
clean sample. These results from each LR+ 
and LR- can be categorized as good.
  Based on the sensitivity and 
specificity results, it can be displayed in 
the receiver operating characteristic (ROC) 
curve (FIGURE 1) with the area under the 
curve (AUC) value of 87.5% which showed 
the NBI validity of after treatment NPC 
biopsy was included in good category. 
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DISCUSSION
The number of male subjects (14 
cases or 70%) were higher than female 
subjects (6 cases or 30%) in this study. It 
was reported that the incidence of NPC in 
the United States was 1-2 cases per 100,000 
males and 0.4 cases per 100,000 females. 
The comparison of male and female NPC 
patients was 3:1.  The incidence of NPC in 
Indonesia also shows a tendency to occur 
more often in men than women with a ratio 
of 2:1.14  In this study, NPC is more common 
in men compared to women with a ratio of 
2.3:1. There is still uncertainty of factors that 
affect NPC more tendency in men. However, 
it is suspected that there are links between 
the NPC incidence with genetic factors, life 
habits, work, and other factors.
Initial signs and symptoms of NPC are 
not typical and non-specific. The nasopharynx 
is a difficult area, so NPC is often diagnosed 
in an advanced stage compared to other 
malignancies. Because it is rich in lymphatic 
supply, cervical metastases are often seen 
in the initial appearance. It was reported 
that among 122 NPC patients visited in the 
hospital, first arrived with regional neck 
metastasis of 54% cases.1,15 This study found 
18 cases (90%) of patients with advanced 
NPC, and only 2 cases (10 %) with stage I 
and II. In addition, from all of them showed 
symptoms of neck mass as many as 15 
cases (75%). Therefore, most of the cases 
in this study received chemoradiotherapy 
treatment.
One effect of radiation on a malignancy 
is the occurrence of a diffuse inflammatory 
reaction in the area of  radiation and its 
surroundings. This one gives an unsure 
picture of a bias residual mass.16 In this 
study, from conventional nasoendoscopic 
examination on both sides of the nasopharynx 
found that there was still residual mass after 
therapy in 6 cases (15%), while 85% of the 
nasopharynx had no mass, slippery surface, 
limfoephitelial picture disappears.
Narrow-band imaging is an optical 
technique that is able to increase the 
diagnostic sensitivity of nasoendoscopic 
examination to assess tissue characteristics 
by using narrow bandwith filter in tissue that 
contain blood vessels. The description of 
NBI will improve the characteristics of the 
mucosa that examined, differentiation, and 
diagnostics.11,12,17
Several studies showed that the 
macroscopic picture of the nasopharyngeal 
wall does not reflect the presence of residual 
or NPC especially in post-radiotherapy 
patients, because the post-radiation 
nasopharyngeal mucosa becomes fibrosis, 
nasopharyngitis, and osteoradionecrosis. 
However, 30% of NPC cases are recurrent 
without any tumor appearance seen on 
endoscopy but histological examination 
revealed malignancy.17
The results of this study can complement 
previous studies that have reported NBI 
nasoendoscopic or NPC screening. Piazza 
et al.18 and Lukes et al.19 reported that NBI 
technique had a sensitivity of 91.3-100% 
and specificity of 91.6-98%. Furthermore, 
it would increase when combined using 
a television screen with an enlargement 
capability and good quality resolution. 
A retrospective study reported that NBI 
was superior in detecting lesions, with a 
sensitivity and specificity of 92.7% and 
94.5% compared to conventional endoscopic, 
about 95.1% and 63%.19
There is a difference in the appearance 
of NBI in NPC after therapy due to lysis 
and death of cancer cells due to exposure 
to chemoradiotherapy. The appearance of 
NPC that experienced recurrence appeared 
as well-defined brownish spots and in 
inhomogen size.17 This study showed 30 
samples (75%) that gave NBI picture in the 
form of homogeneous and regular brown 
spots, and 10 samples (25%) showed an 
inhomogenous picture.
There were limitations in this study, 
including the absence of comparison between 
nasoendoscopy NBI and conventional so 
that there is a difference between the two, 
due to ethical considerations and techniques 
of action taken at the polyclinic under local 
anesthesia.
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CONCLUSION
Validity of NBI nasoendoscopy on post-
treatment nasopharyngeal cancer biopsy is 
good. The NBI can improve the accuracy of 
nasopharyngeal biopsy in NPC post therapy.
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